BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 38598542)

  • 1. Interference with mitochondrial metabolism could serve as a potential therapeutic strategy for advanced prostate cancer.
    Wu C; Zhu H; Zhang Y; Ding L; Wang J
    PLoS One; 2024; 19(4):e0290753. PubMed ID: 38598542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
    Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
    Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer.
    Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
    PeerJ; 2022; 10():e14263. PubMed ID: 36312753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
    Zhang J; Wang Y; Ma J; Aimudula A
    Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Cancers.
    Ye Z; Zhang H; Kong F; Lan J; Yi S; Jia W; Zheng S; Guo Y; Zhan X
    Oxid Med Cell Longev; 2021; 2021():9259297. PubMed ID: 34970420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juglone promotes antitumor activity against prostate cancer via suppressing glycolysis and oxidative phosphorylation.
    Hu C; Xu H; Li Z; Liu D; Zhang S; Fang F; Wang L
    Phytother Res; 2023 Feb; 37(2):515-526. PubMed ID: 36281060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer.
    Henning GM; Barashi NS; Smith ZL
    Clin Genitourin Cancer; 2021 Jun; 19(3):194-198. PubMed ID: 33781702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer statistics, 2020.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Energetics and Biosynthesis.
    Lin C; Salzillo TC; Bader DA; Wilkenfeld SR; Awad D; Pulliam TL; Dutta P; Pudakalakatti S; Titus M; McGuire SE; Bhattacharya PK; Frigo DE
    Adv Exp Med Biol; 2019; 1210():185-237. PubMed ID: 31900911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.
    Lu-Yao G; Nikita N; Keith SW; Nightingale G; Gandhi K; Hegarty SE; Rebbeck TR; Chapman A; Kantoff PW; Cullen J; Gomella L; Kelly WK
    Eur Urol; 2020 Feb; 77(2):158-166. PubMed ID: 31420248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.
    Boysen G; Rodrigues DN; Rescigno P; Seed G; Dolling D; Riisnaes R; Crespo M; Zafeiriou Z; Sumanasuriya S; Bianchini D; Hunt J; Moloney D; Perez-Lopez R; Tunariu N; Miranda S; Figueiredo I; Ferreira A; Christova R; Gil V; Aziz S; Bertan C; de Oliveira FM; Atkin M; Clarke M; Goodall J; Sharp A; MacDonald T; Rubin MA; Yuan W; Barbieri CE; Carreira S; Mateo J; de Bono JS
    Clin Cancer Res; 2018 Nov; 24(22):5585-5593. PubMed ID: 30068710
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.